The major players in the glucagon-like peptide 1 (GLP-1) agonist market are Eli Lilly and Company, Sanofi, Novo-Nordisk A/S, AstraZeneca, Pfizer.Inc, Amgen, Inc., Innovent Biologics, Inc., PegBio Co., Ltd, Sun Pharmaceutical Industries Ltd
However, some particularly sensitive proteins or peptide fragments may require sterile water without preservative researchers should consult specific product documentation when working with novel compounds
The platform is a technology company that connects patients to independent clinicians
Hyperglycemia and incidence of frailty and lower extremity mobility limitations in older women
In the United States, between 3 to 6 % of the population are vitamin B12 deficient and up to 20% have marginally depleted levels (3)